RBBP9 and colitis: Furthermore, consistent with the notion that the enhanced susceptibility of Rbbp9-/- mice to DSS-induced colitis is attributed to increased bacterial invasion due to impaired barrier function, treatment with broad-spectrum antibiotics abolished the enhanced body weight loss and shortened colon length observed in DSS-treated Rbbp9-/- mice (Figure 7B–D).